Alterations of Chemotherapeutic Pharmacokinetic Profiles by Drug–drug Interactions

Expert Opinion on Drug Metabolism and Toxicology - United Kingdom
doi 10.1517/17425250902753212
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa Healthcare

Related search

Mechanisms and Clinical Significance of Pharmacokinetic-Based Drug-Drug Interactions With Drugs Approved by the U.S. Food and Drug Administration in 2017

Drug Metabolism and Disposition
PharmacologyPharmaceutical Science
2018English

Prediction of Renal Transporter Mediated Drug-Drug Interactions for Pemetrexed Using Physiologically Based Pharmacokinetic Modeling

Drug Metabolism and Disposition
PharmacologyPharmaceutical Science
2014English

Identifying Drug–Drug Interactions by Data Mining

Circulation. Cardiovascular quality and outcomes
MedicineCardiovascular MedicineCardiology
2016English

Drug-Drug Interactions

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
2013English

Application of Physiologically Based Pharmacokinetic Modeling to the Understanding of Bosutinib Pharmacokinetics: Prediction of Drug–Drug and Drug–Disease Interactions

Drug Metabolism and Disposition
PharmacologyPharmaceutical Science
2017English

Data-Driven Prediction of Adverse Drug Reactions Induced by Drug-Drug Interactions

BMC pharmacology & toxicology
MedicinePharmacology
2017English

Perpetrators of Pharmacokinetic Drug-Drug Interactions Arising From Altered Cytochrome P450 Activity: A Criteria-Based Assessment

British Journal of Clinical Pharmacology
Pharmacology
2011English

NOACs: Drug-Drug Interactions

CMAJ
Medicine
2016English

Physiologically Based Pharmacokinetic (Pbpk) Model of the Cyp2d6 Probe Atomoxetine: Extrapolation to Special Populations and Drug-Drug Interactions

Drug Metabolism and Disposition
PharmacologyPharmaceutical Science
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy